NKT Cell-based Glycolipid Immunotherapy of Biphasic Sepsis Skip to main content
Technologies

NKT Cell-based Glycolipid Immunotherapy of Biphasic Sepsis

ID: 2020-044 NKT Cell-based Glycolipid Immunotherapy of Biphasic Sepsis

Reach out to us directly to learn more about this technology - Phone: (801) 422-6266